Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000492443 | SCV000581138 | pathogenic | Hereditary cancer-predisposing syndrome | 2016-01-05 | criteria provided, single submitter | clinical testing | The c.844delC pathogenic mutation, located in coding exon 7 of the TP53 gene, results from a deletion of one nucleotide at position 844, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |
Myriad Genetics, |
RCV004023280 | SCV004931563 | pathogenic | Li-Fraumeni syndrome 1 | 2024-02-21 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |